Cargando…

Trans-arterial chemoembolization combined with Jinlong capsule for advanced hepatocellular carcinoma: a PRISMA-compliant meta-analysis in a Chinese population

CONTEXT: Jinlong capsule (JLC) is an animal-derived traditional Chinese medical preparation for advanced hepatocellular carcinoma (HCC). However, its clinical efficacy is still not well investigated. OBJECTIVE: This study summarizes the efficacy and safety of JLC combined with trans-arterial chemoem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Shuzhao, Fu, Ying, Tao, Huimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470052/ https://www.ncbi.nlm.nih.gov/pubmed/32767901 http://dx.doi.org/10.1080/13880209.2020.1799040

Ejemplares similares

Efficacy and safety of Chinese patent medicine (Jinlong capsule) in the treatment of advanced hepatocellular carcinoma: a meta-analysis
por: Xu, He, et al.
Publicado: (2020)

Chinese patent medicine (Jinlong Capsule) for gastric cancer: Protocol for a systematic review and meta-analysis
por: Li, Jianwei, et al.
Publicado: (2020)

Transcatheter hepatic arterial chemoembolization combined with Kangai injection for hepatitis B virus-related hepatocellular carcinoma: A protocol for a PRISMA-compliant meta-analysis
por: Wang, Wanpeng, et al.
Publicado: (2020)

Jinlong capsule inhibits migration and invasion in human glioblastoma cells via the modulation of mTOR/S6 signaling pathway
por: Shi, Jingren, et al.
Publicado: (2019)

Trans-Arterial Chemoembolization Plus Systemic Treatments for Hepatocellular Carcinoma: An Update
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Comprehensive Treatment of Trans-Arterial Chemoembolization Plus Lenvatinib Followed by Camrelizumab for Advanced Hepatocellular Carcinoma Patients
por: Liu, Juanfang, et al.
Publicado: (2021)

Comparable Outcomes in Early Hepatocellular Carcinomas Treated with Trans-Arterial Chemoembolization and Radiofrequency Ablation
por: Tay, Benjamin Wei Rong, et al.
Publicado: (2022)

Diagnostic value of long noncoding RNAs for hepatocellular carcinoma: A PRISMA-compliant meta-analysis
por: Hao, Qing-Qin, et al.
Publicado: (2017)

Treatment algorithm based on the multivariate survival analyses in patients with advanced hepatocellular carcinoma treated with trans-arterial chemoembolization
por: Prajapati, Hasmukh J., et al.
Publicado: (2017)

Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma
por: Park, Yehyun, et al.
Publicado: (2019)

The clinical efficacy and safety of kanglaite adjuvant therapy in the treatment of advanced hepatocellular carcinoma: A PRISMA-compliant meta-analysis
por: Liu, Jingjing, et al.
Publicado: (2019)

Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation
por: Yun, Byung-Yoon, et al.
Publicado: (2020)

Safety and Efficacy of Drug-Eluting Beads Trans-Arterial Chemoembolization for Hepatocellular Carcinoma in Taiwan (SERENADE-T)
por: Liu, Yi-Sheng, et al.
Publicado: (2022)

Changes of alpha-fetoprotein levels could predict recurrent hepatocellular carcinoma survival after trans-arterial chemoembolization
por: He, Chao, et al.
Publicado: (2017)

Adult split liver transplantation: A PRISMA-compliant Chinese single-center retrospective case-control study
por: Kong, Lingxiang, et al.
Publicado: (2020)

Effectiveness of Chinese herbal medicine for patients with primary insomnia: A PRISMA-compliant meta-analysis
por: Zhang, Hongshi, et al.
Publicado: (2019)

Mycophenolate mofetil in the treatment of Chinese patients with lupus nephritis: A PRISMA-compliant meta-analysis
por: Zhang, Haitao, et al.
Publicado: (2020)

A PRISMA-compliant systematic review and meta-analysis of integrated Chinese and Western medicine in treating hepatitis C
por: Li, Xiuqin, et al.
Publicado: (2020)

Prognostic and clinicopathological significance of Gamma-Glutamyltransferase in patients with hepatocellular carcinoma: A PRISMA-compliant meta-analysis
por: Sun, Ping, et al.
Publicado: (2019)

Clinical importance of the superficial temporal artery in neurovascular diseases: A PRISMA-compliant systematic review
por: Hou, Kun, et al.
Publicado: (2019)

Chemoembolization for hepatocellular carcinoma fed by right internal thoracic artery
por: Shen, Tao, et al.
Publicado: (2017)

Scheduled Interval Trans-Catheter Arterial Chemoembolization Followed by Radiation Therapy in Patients with Unresectable Hepatocellular Carcinoma
por: Yu, Jeong Il, et al.
Publicado: (2012)

Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma
por: Pinato, David J., et al.
Publicado: (2018)

Radiological appearance of hepatocellular carcinoma predicts the response to trans-arterial chemoembolization in patients undergoing liver transplantation
por: Zhang, Wei, et al.
Publicado: (2019)

Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis
por: Roth, Gaël S., et al.
Publicado: (2021)

Optimal timing of combining sorafenib with trans-arterial chemoembolization in patients with hepatocellular carcinoma: A meta-analysis
por: Dai, Yanmei, et al.
Publicado: (2021)

Can S-1 replace fluorouracil for advanced gastric cancer? A PRISMA-compliant systematic review and meta-analysis
por: Chen, Xiao-Dong, et al.
Publicado: (2016)

Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization
por: Kobayashi, Saito, et al.
Publicado: (2020)

Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced hepatocellular carcinoma
por: NISHIKAWA, HIROKI, et al.
Publicado: (2012)

Trans-catheter arterial chemoembolization plus Sorafenib, an unsuccessful therapy in the treatment of hepatocellular carcinoma?: A systematic review and meta-analysis
por: Zhang, Tao, et al.
Publicado: (2020)

Traditional Chinese biomedical preparation (Huaier Granule) for breast cancer: a PRISMA-compliant meta-analysis
por: Yao, Xialei, et al.
Publicado: (2020)

Effect of magnesium sulfate on renal colic pain: A PRISMA-compliant meta-analysis
por: Chen, Liang-Fu, et al.
Publicado: (2020)

Immunoadsorption treatment for dilated cardiomyopathy: A PRISMA-compliant systematic review and meta-analysis
por: Bian, Ru-tao, et al.
Publicado: (2021)

Treatment of solitary hepatocellular carcinoma up to 2 cm: A PRISMA-compliant systematic review and meta-analysis
por: Fan, Hongyan, et al.
Publicado: (2020)

Initial Experience of Drug-Eluting Bead-Transcatheter Arterial Chemoembolization After Lipiodol-Based Transcatheter Arterial Chemoembolization Failure for Patients with Advanced Hepatocellular Carcinoma
por: Liu, Kai-Cai, et al.
Publicado: (2021)

Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy.
por: Pinato, David J., et al.
Publicado: (2021)

Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysis
por: Cai, Rong, et al.
Publicado: (2017)

Cutaneous fistulization of the hydatid disease: A PRISMA-compliant systematic review
por: Bahce, Zeynep Sener, et al.
Publicado: (2016)

Prevalence of depression in myocardial infarction: A PRISMA-compliant meta-analysis
por: Feng, Limin, et al.
Publicado: (2019)

Pediatric plexiform fibromyxoma: A PRISMA-compliant systematic literature review
por: Fukazawa, Mitsuharu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j0v8rdspi0h6n2jeafbqifkgiu